TOMI and Cellares to Collaborate on the Integration of SteraMist iHP Technology into Revolutionary New Cell Therapy Manufacturing Solution
August 03 2023 - 8:30AM
TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a
global company specializing in disinfection and decontamination
solutions, today announced a collaboration with Cellares to
integrate its SteraMist ionized Hydrogen Peroxide (iHP) technology
into a revolutionary new cell therapy manufacturing solution, the
Cell Shuttle, designed and produced by Cellares.
The Cellares Cell Shuttle is a breakthrough in automated cell
therapy manufacturing, offering end-to-end automation and reducing
inefficiencies. This revolutionary system enables fully automated
production of cell therapies for up to 16 different patients
simultaneously, a significant increase in yield compared to
traditional manufacturing methods.
Due to the critical importance of maintaining a sterile
environment within the confined spaces of the Cell Shuttle,
Cellares selected TOMI's patented iHP decontamination technology.
The SteraMist iHP technology ensures comprehensive decontamination
with its small micron particles, offering advantages in efficacy
and safety over other commercially available decontamination
methods.
TOMI and Cellares began their partnership in 2021 and are now in
the final stages of iHP Cell Shuttle prototypes. TOMI has developed
a new sleek, clean, compliant, and efficient system for integration
into the Cell Shuttle. These systems are designed to be compact
while maintaining all industry standards that SteraMist iHP
technology represents.
“Our collaboration with TOMI and SteraMist iHP technology has
been instrumental in bringing effective decontamination to the Cell
Shuttle,” stated Daniele Malleo, PhD, VP of Research &
Development at Cellares. “We are confident that our design, coupled
with the SteraMist iHP decontamination, will set the standard for
cell-therapy manufacturing in the industry.”
“We are incredibly excited that Cellares is working with our
team to achieve seamless integration of our technology into their
groundbreaking Cell Shuttle. It has been a pleasure collaborating
with their research and development team to develop a tailor-made
SteraMist iHP system, designed to meet their requirements and be
offered alongside their product,” Elissa J. (E.J.) Shane, TOMI’s
COO, states. “We continue to seek out and build strong partnerships
with leading life science manufactures where there is a need for
all the advantages of SteraMist iHP disinfection technology.”
TOMI™ Environmental Solutions, Inc.: Innovating for a
safer world®
TOMI™ Environmental Solutions, Inc. (NASDAQ: TOMZ) is a
global decontamination and infection prevention company, providing
environmental solutions for disinfection through the manufacturing,
sales and licensing of its premier Binary Ionization Technology ®
(BIT™) platform. Invented under a defense grant in association with
the Defense Advanced Research Projects Agency (DARPA) of the U.S.
Department of Defense, BIT™ solution utilizes a low percentage
hydrogen peroxide as its only active ingredient and uses patented
ionized Hydrogen Peroxide (iHP™) technology in all SteraMist
systems to create superior disinfection. TOMI products are
designed to service a broad spectrum of use sites, including, but
not limited to, hospitals and medical facilities, biosafety labs,
pharmaceutical facilities, commercial and office buildings,
schools, restaurants, meat and produce processing facilities, and
police and fire departments.
For additional information, please visit
http://www.tomimist.com/ or contact us at
info@tomimist.com
Safe Harbor Statement under the Private Securities Litigation
Reform Act of 1995
This press release contains forward-looking statements that are
based on current expectations, estimates, forecasts and projections
of future performance based on management’s judgment, beliefs,
current trends, and anticipated product performance. These
forward-looking statements include, without limitation, statements
relating to collaboration with Cellares and anticipated sales based
on such collaboration. Forward-looking statements involve risks and
uncertainties that may cause actual results to differ materially
from those contained in the forward-looking statements. These
factors include, but are not limited to, our ability to generate
sales and increase revenue, our reliance on a single or a few
products for a majority of revenues; the general business and
economic conditions; and other risks as described in our SEC
filings, including our Annual Report on Form 10-K for the fiscal
year ended December 31, 2021 filed by us with the SEC and other
periodic reports we filed with the SEC. The information provided in
this document is based upon the facts and circumstances known at
this time. Other unknown or unpredictable factors or underlying
assumptions subsequently proving to be incorrect could cause actual
results to differ materially from those in the forward-looking
statements. Although we believe that the expectations reflected in
the forward-looking statements are reasonable, we cannot guarantee
future results, level of activity, performance, or achievements.
You should not place undue reliance on these forward-looking
statements. All information provided in this press release is as of
today’s date, unless otherwise stated, and we undertake no duty to
update such information, except as required under applicable
law.
INVESTOR RELATIONS CONTACT:
John Nesbett/Roz Christian
IMS Investor Relations
tomi@imsinvestorrelations.com
TOMI Environmental Solut... (NASDAQ:TOMZ)
Historical Stock Chart
From Apr 2024 to May 2024
TOMI Environmental Solut... (NASDAQ:TOMZ)
Historical Stock Chart
From May 2023 to May 2024